Owner TAKEDA CHEMICAL INDUSTRIES, LTD.

Inventors KAIEDA, Isao; HONDA, Kohei; TANAKA, Hiroshi

Pub. Number AU-A-2003289385

PCT Number PCT/JP2003/0161

PCT Pub. Number WO2004/055185

Priority 2002-366732 18.12.02 JP; 2003-73974 18.03.03 JP

Filing date 17 December 2003

Wipo publication date 9 July 2004

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

A61K 039/00 Medicinal preparations containing antigens or antibodies

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 003/10 Drugs for disorders of the metabolism

A61P 013/12 Drugs for disorders of the urinary system

A61P 021/04 Drugs for disorders of the muscular or neuromuscular system

A61P 025/00 Drugs for disorders of the nervous system

A61P 025/16 Drugs for disorders of the nervous system

A61P 025/28 Drugs for disorders of the nervous system

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 035/00 Antineoplastic agents

A61P 037/02 Drugs for immunological or allergic disorders

A61P 043/00 Drugs for specific purposes, not provided for in groups

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12N 001/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C07K 014/82 Peptides having more than 20 amino acids - Translation products from oncogenes

C07K 016/32 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 021/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 031/7088 - Compounds having three or more nucleosides or nucleotides